Immune Pharma (IMNP) Closes 3.45M Common Units Offering for Proceeds of $8.625M
Tweet Send to a Friend
Immune Pharma (NASDAQ: IMNP) announced the closing of its previously announced underwritten public offering of 3,450,000 units, with each unit ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
